Nektar Therapeutics (NKTR) Tops Q2 EPS by 4c
Tweet Send to a Friend
Nektar Therapeutics (NASDAQ: NKTR) reported Q2 EPS of ($0.30), $0.04 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
